SAN CARLOS, Calif.-- October 14, 2026 -- Altay Therapeutics, Inc., a biotechnology company developing novel small molecule inhibitors of transcription factors, today announced the completion of a $37 million Series...
Jayson Punwani will moderate a panel at the 2nd annual Kenan-Flagler Business School Health Care conference on financing innovation.
News | 10. 29. 2012
Jayson Punwani will moderate a panel at the 2nd annual Kenan-Flagler Business School Health Care conference on financing innovation.
